No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Could The Market Be Wrong About BioSyent Inc. (CVE:RX) Given Its Attractive Financial Prospects?
Biosyent Inc: ANNUAL REPORT EN
BioSyent to Present at LD Micro New York Investor Conference
FeraMAX Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Tenth Consecutive Year
BioSyent Announces Grant of Restricted Share Units
Earnings Call Summary | BIOSYENT INC(BIOYF.US) Q4 2024 Earnings Conference